Compound Detail
CHEMBL513909
BI-2536 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
Basic Information
| ChEMBL ID | CHEMBL513909 |
| Name | BI-2536 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | XQVVPGYIWAGRNI-JOCHJYFZSA-N |
488
Targets
638
Activities
4
Assay Types
30
PK Parameters
20
Publications
3
Known Names
7
Indications
1
Mechanisms
Molecular Properties
521.7
MW (Da)
3.56
ALogP
8
HBA
2
HBD
102.9
PSA (Ų)
0.57
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase PLK1 inhibitor | INHIBITOR | Serine/threonine-protein kinase PLK1 | ✓ | ✓ |
Indications
Carcinoma, Non-Small-Cell Lung Leukemia, Myeloid, Acute Pancreatic Neoplasms Prostatic Neoplasms Small Cell Lung Carcinoma Lymphoma Neoplasms
Activity Summary
IC50 469 meas. best 10.08
Kd 128 meas. best 9.72
EC50 38 meas. best 8.7
Ki 3 meas. best 9.66
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serine/threonine-protein kinase PLK1 CHEMBL3024 | IC50 | 10.08 | 8.716 | 0.1 | 30 |
| Serine/threonine-protein kinase PLK1 CHEMBL3024 | Kd | 9.72 | 9.72 | 0.2 | 3 |
| Serine/threonine-protein kinase PLK1 CHEMBL3024 | Ki | 9.66 | 9.09 | 0.2 | 2 |
| HEK-293T CHEMBL3706568 | IC50 | 9.22 | 9.11 | 0.6 | 2 |
| Serine/threonine-protein kinase PLK2 CHEMBL5938 | Kd | 9.09 | 9.09 | 0.8 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 9.0 | 7.93 | 1.0 | 3 |
| MM1.S CHEMBL4296471 | IC50 | 9.0 | 8.96 | 1.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 9.0 | 7.2283 | 1.0 | 6 |
| Bromodomain-containing protein 4 CHEMBL1163125 | IC50 | 8.92 | 7.2525 | 1.2 | 16 |
| Serine/threonine-protein kinase PLK3 CHEMBL4897 | IC50 | 8.79 | 7.925 | 1.6 | 8 |
| H4 CHEMBL1075452 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| Bromodomain-containing protein 4 CHEMBL1163125 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| DOHH-2 CHEMBL2366181 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| Serine/threonine-protein kinase PLK1 CHEMBL3024 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| HL-60 CHEMBL383 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| HT-29 CHEMBL384 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| K562 CHEMBL385 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| MCF7 CHEMBL387 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| PC-3 CHEMBL390 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| A549 CHEMBL392 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| HCT-116 CHEMBL394 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| HepG2 CHEMBL395 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| NCI-H460 CHEMBL396 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| HeLa S3 CHEMBL4296436 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| Granta-519 CHEMBL4483240 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| MDA-MB-435S CHEMBL4483284 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| FaDu CHEMBL612250 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| DU-145 CHEMBL613508 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| A-375 CHEMBL613859 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| A-431 CHEMBL614069 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| NCI-H520 CHEMBL614099 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| PANC-1 CHEMBL614139 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| NCI-N87 CHEMBL614197 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| THP-1 CHEMBL614245 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| MES-SA CHEMBL614343 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| BXPC-3 CHEMBL614530 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| COLO 205 CHEMBL614561 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| Raji CHEMBL614628 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| BRO melanoma cell line CHEMBL614665 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| Skut1B CHEMBL614678 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| MIA PaCa-2 CHEMBL614725 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| SAOS-2 CHEMBL614894 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| SK-MEL-28 CHEMBL614919 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| SK-OV-3 CHEMBL614925 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| Serine/threonine-protein kinase PLK2 CHEMBL5938 | IC50 | 8.54 | 8.1578 | 2.9 | 9 |
| Serine/threonine-protein kinase PLK3 CHEMBL4897 | Kd | 8.4 | 8.4 | 4.0 | 1 |
| MDA-MB-361 CHEMBL614129 | IC50 | 8.29 | 8.29 | 5.1 | 1 |
| PSN1 CHEMBL614241 | IC50 | 8.11 | 8.11 | 7.8 | 1 |
| ACN CHEMBL2366195 | IC50 | 8.07 | 8.07 | 8.4 | 1 |
| TE-8 CHEMBL2366182 | IC50 | 8.03 | 8.03 | 9.4 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 283.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 556.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 198.0 | ng.hr.mL-1 | Mus musculus |
| CL | 51.1 | mL.min-1.g-1 | Homo sapiens |
| CL | 22.2 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 48.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 39.9 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 95.3 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 51.1 | mL.min-1.g-1 | Homo sapiens |
| CL | 48.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 22.2 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 39.9 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 83.4 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 122.68 | nM | Rattus norvegicus |
| Cmax | 316.29 | nM | Mus musculus |
| F | 16.3 | % | Rattus norvegicus |
| F | 28.5 | % | Mus musculus |
| Fu | 0.0452 | - | Homo sapiens |
| Fu | 0.0936 | - | Macaca fascicularis |
| Fu | 0.0491 | - | Canis lupus familiaris |
| Fu | 0.114 | - | Rattus norvegicus |
| Fu | 0.0452 | - | Homo sapiens |
| Fu | 0.0936 | - | Macaca fascicularis |
| Fu | 4.91 | - | Canis lupus familiaris |
| Fu | 0.114 | - | Mus musculus |
| T1/2 | 0.4517 | hr | Homo sapiens |
| T1/2 | 1.045 | hr | Rattus norvegicus |
| T1/2 | 1.56 | hr | Rattus norvegicus |
| T1/2 | 1.44 | hr | Rattus norvegicus |
| T1/2 | 0.4517 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | HEK-293T | 261 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 259 |
| - | 10.6019/CHEMBL4689842 | U2OS | 259 |
| 36889251 | 10.1016/j.ejmech.2023.115242 | ADMET | 33 |
| 38364599 | 10.1016/j.bmc.2024.117609 | ADMET | 32 |
| 17291761 | 10.1016/j.cub.2006.12.046 | HeLa | 24 |
| 17291761 | 10.1016/j.cub.2006.12.046 | Serine/threonine-protein kinase PLK1 | 22 |
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 17291758 | 10.1016/j.cub.2006.12.037 | HeLa | 15 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 26254279 | 10.18632/oncotarget.4214 | Serine/threonine-protein kinase PLK1 | 9 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 9 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 8 |
| 34735919 | 10.1016/j.ejmech.2021.113926 | Unchecked | 8 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 35191694 | 10.1021/acs.jmedchem.1c01999 | Transcription initiation factor TFIID subunit 1 | 7 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
Data from ChEMBL 36 via Core Engine